Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Omnicell (OMCL) Common Equity (2016 - 2025)

Historic Common Equity for Omnicell (OMCL) over the last 16 years, with Q3 2025 value amounting to $1.2 billion.

  • Omnicell's Common Equity fell 84.67% to $1.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 billion, marking a year-over-year decrease of 84.67%. This contributed to the annual value of $1.2 billion for FY2024, which is 457.2% up from last year.
  • Latest data reveals that Omnicell reported Common Equity of $1.2 billion as of Q3 2025, which was down 84.67% from $1.3 billion recorded in Q2 2025.
  • In the past 5 years, Omnicell's Common Equity ranged from a high of $1.3 billion in Q2 2025 and a low of $1.0 billion during Q1 2021
  • Its 5-year average for Common Equity is $1.2 billion, with a median of $1.2 billion in 2023.
  • In the last 5 years, Omnicell's Common Equity skyrocketed by 2100.8% in 2021 and then crashed by 144.35% in 2022.
  • Over the past 5 years, Omnicell's Common Equity (Quarter) stood at $1.1 billion in 2021, then decreased by 1.44% to $1.1 billion in 2022, then increased by 5.2% to $1.2 billion in 2023, then grew by 4.57% to $1.2 billion in 2024, then fell by 1.8% to $1.2 billion in 2025.
  • Its Common Equity was $1.2 billion in Q3 2025, compared to $1.3 billion in Q2 2025 and $1.3 billion in Q1 2025.